MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Development"

  • MDS Virtual Congress 2020

    Feasibility of a simplified, symptom-based electronic diary to improve evaluation of motor and non-motor complications in Parkinson’s disease

    O. Chuapakdee, P. Punyakaew, V. Ratanasirisawad, S. Kongdachalert, C. Winyooviji, R. Bhidayasiri (Bangkok, Thailand)

    Objective: To determine the feasibility of the simplified and symptom-based electronic PD diary and compare with the standard paper diary. Background: Motor complications (MC) is…
  • MDS Virtual Congress 2020

    Visuomotor reaction time can predict IQ in children

    S. Kiselev (Ekaterinburg, Russian Federation)

    Objective: This study investigated whether visuomotor reaction time in 5 year-old children predicts intelligence test scores in 8 year-old children using the longitudinal approach. Background:…
  • MDS Virtual Congress 2020

    Home Based Care: A care pathway innovation for Parkinson’s disease

    E. Edwards, R. Partridge, U. Ankeny, J. Langley, S. Whipps, J. Whipps, J. Rideout, A. Evans, S. Bentley, M. Swabey, H. Matthews, N. Stevens, R. Chivers, T. Dominey, K. Triscott, C. Carroll (Plymouth, United Kingdom)

    Objective: To create a new care pathway that puts the needs of the patient at the centre of service design and delivery. Background: The traditional…
  • MDS Virtual Congress 2020

    Burden of variants in Parkinson’s disease-associated genes in GBA mutation carriers

    Y.L Sosero, E. Yu, P. Saini, L. Krohn, U. Rudakou, J. Ruskey, F. Asayesh, M. Estiar, S. Fahn, C. Waters, O. Monchi, Y. Dauvilliers, A. Espay, N. Dupré, L. Greenbaum, G. Rouleau, S. Hassin-Baer, E. Fon, R. Alcalay, Z. Gan-Or (Montreal, QC, Canada)

    Objective: The main objective of this study is to examine the burden of variants in genes that are known or suspected to be involved in…
  • MDS Virtual Congress 2020

    Male-specific exacerbation of susceptibility to α-synuclein pre-formed fibrils by developmental dieldrin exposure in mice

    A. Gezer, J. Kochmanski, S. VanOeveren, A. Cole-Strauss, C. Kemp, J. Patterson, K. Miller, N. Kuhn, D. Herman, A. McIntire, J. Lipton, K. Luk, S. Fleming, C. Sortwell, A. Bernstein (Grand Rapids, MI, USA)

    Objective: To determine whether developmental exposure to dieldrin exacerbates susceptibility to α-synuclein (α-syn) preformed fibril (PFF)-induced synucleinopathy in adulthood. Background: Parkinson’s disease (PD) is characterized…
  • MDS Virtual Congress 2020

    Early life stress offers a window into the relationship between depression and Parkinson’s disease: A 60-week study after maternal separation in rats

    C. Ren, K.J He, Y.T Zhang, J.B Zhang, F. Wang, C.F Liu (Suzhou, China)

    Objective: The aim of this study was to examine the relationship between depression and Parkinson's disease (PD) using the rat model of maternal separation (MS).…
  • MDS Virtual Congress 2020

    The Personalized Parkinson Project – data quality enhancing strategies

    B. Bloem, L. Evers, T. vande Zande, R. Kapur, M. Meinders, W. Marks, Jr (Nijmegen, Netherlands)

    Objective: Demonstrate the impact of quality enhancing strategies in the Personalized Parkinson Project. Background: Increasingly, the scientific community uses data from longitudinal observational patient cohorts…
  • 2019 International Congress

    A Human Factors Study of the DopaFuse® Delivery System

    J. Harmon, S. Japp, C. Long, J. Spiridigliozzi, A. Heller, B. Heller, C. King, P. Plante, R. Draper, T. Lau, E. Heller (Bala Cynwyd, PA, USA)

    Objective: SynAgile has developed the DopaFuse Delivery System to noninvasively and continuously administer oral LD/CD into the mouths of patients with PD. The System is…
  • 2019 International Congress

    Increasing chances of detecting a neuroprotective signal in PhI/II PD clinical trials?

    S. Palfi, C. Denot, A. Bousseau, JC. Corvol (Paris, France)

    Objective: Design an early CT program to detect a neuroprotective signal in PD. Background: Attempts to develop PD modifying therapies have been largely disappointing so…
  • 2019 International Congress

    5 cases Static Encephalopathy of childhood with NeuroDegeneration in Adulthood (OMIM 300894) in children

    M. Bobylova, N. Perumova, T. Prygunova, K. Mukhin (Moscow, Russian Federation)

    Objective: 5 russian female patients aged 3 to 6 years with different mutations of the WDR45 gene were examined. Background: To study the clinical picture…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 8
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Nilotinib for treating MSA: A preclinical proof of concept study
  • Patients with Essential Tremor Live Longer than their Relatives
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley